Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Markus Schuerch"'
Autor:
Nadia Foskett, Scott L. DuVall, Kristin Knippenberg, Markus Schuerch, Joanne LaFleur, Y. Xie, Richard E. Nelson, Aaron W. C. Kamauu, Jorie Butler
Publikováno v:
International Journal of MS Care. 17:221-230
Background: This study estimated the risk of infection-related hospitalizations and death in patients with and without multiple sclerosis (MS). Methods: We identified adults with MS in the US Department of Veterans Affairs (VA) system between 1999 an
Publikováno v:
Neurology. 81:910-919
Objective: To explore the risk of ischemic stroke, hemorrhagic stroke, or TIA in patients with Alzheimer disease (AD) or vascular dementia (VD). Methods: We conducted a follow-up study with a nested case-control analysis using the UK-based General Pr
Autor:
Jakob Christensen, Yolanda Alvarez, Ulrik Hesse, Robert Walls, Ole Mors, Raymond G. Schlienger, Mark C.H. De Groot, Olaf H. Klungel, Frank de Vries, Christiane Gasse, Robert F. Reynolds, Markus Schuerch, Noah Jamie Robinson
Publikováno v:
Schuerch, M, Gasse, C, Robinson, N J, Alvarez, Y, Walls, R, Mors, O, Christensen, J, Hesse, U, de Groot, M, Schlienger, R, Reynolds, R, Klungel, O & de Vries, F 2016, ' Impact of varying outcomes and definitions of suicidality on the associations of antiepileptic drugs and suicidality : comparisons from UK Clinical Practice Research Datalink (CPRD) and Danish national registries (DNR) ', Pharmacoepidemiology and Drug Safety, vol. 25, no. Supplement S1, pp. 142-55 . https://doi.org/10.1002/pds.3928
Pharmacoepidemiology and Drug Safety, 25(Suppl 1), 142-155. Wiley
Pharmacoepidemiology and Drug Safety, 25(S1), 142. John Wiley and Sons Ltd
Pharmacoepidemiology and Drug Safety, 25(Suppl S1), 142. John Wiley and Sons Ltd
Pharmacoepidemiology and Drug Safety, 25(Suppl 1), 142-155. Wiley
Pharmacoepidemiology and Drug Safety, 25(S1), 142. John Wiley and Sons Ltd
Pharmacoepidemiology and Drug Safety, 25(Suppl S1), 142. John Wiley and Sons Ltd
PURPOSE: The purpose of this study is to quantify the impact of the different outcomes and definitions of suicidality on the association between antiepileptic drugs (AEDs) and suicidality.METHODS: Retrospective cohort studies of selected AEDs (carbam
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6028632aaf149693f6c0b34fc2e6400
https://pure.au.dk/portal/da/publications/impact-of-varying-outcomes-and-definitions-of-suicidality-on-the-associations-of-antiepileptic-drugs-and-suicidality(715e9c33-75a5-49c8-b245-e5b356bc883e).html
https://pure.au.dk/portal/da/publications/impact-of-varying-outcomes-and-definitions-of-suicidality-on-the-associations-of-antiepileptic-drugs-and-suicidality(715e9c33-75a5-49c8-b245-e5b356bc883e).html
Publikováno v:
Epilepsia. 54:700-707
Purpose: Patients with Alzheimer's disease (AD) have an increased risk of developing seizures or epilepsy. Little is known about the role of risk factors and about the risk of developing seizures/epilepsy in patients with vascular dementia (VD). The
Autor:
Richard E. Nelson, Joanne LaFleur, Y. Xie, Aaron W. C. Kamauu, Markus Schuerch, Nadia Foskett
Publikováno v:
Value in Health. 16(3)
Publikováno v:
Epilepsia. 54(4)
Patients with Alzheimer's disease (AD) have an increased risk of developing seizures or epilepsy. Little is known about the role of risk factors and about the risk of developing seizures/epilepsy in patients with vascular dementia (VD). The aim of th
Autor:
Nadia Foskett, Joanne LaFleur, Aaron W. C. Kamauu, Markus Schuerch, Richard E. Nelson, Y. Xie
Publikováno v:
Value in Health. 16(3):A79-A80